Drug Type Small molecule drug |
Synonyms CCG-232964 |
Target |
Mechanism MRTFB inhibitors(myocardin related transcription factor B inhibitors), RHO inhibitors(Rhodopsin inhibitors), SRF inhibitors(Serum response factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15ClN2O3S |
InChIKeyAKQOOCVXRXDGNN-UHFFFAOYSA-N |
CAS Registry2349373-70-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Scleroderma, Systemic | Preclinical | US | 18 Apr 2019 |